BOSTON -- In deciding on anticoagulation with apixaban (Eliquis) for patients with device-detected, subclinical atrial fibrillation (SCAF), one key number appeared to distinguish those for whom the ...

Retrospective data support use of oral anticoagulants for death and MACE risk reduction in patients with end-stage kidney disease and nonvalvular atrial fibrillation who have an elevated CHA2DS2-VASc ...

I recently saw four patients in one morning who had atrial fibrillation and either one or two risk factors for stroke. None had symptoms warranting rhythm control or tachycardia requiring rate-control ...

image: Combining two independent, scientifically-proven risk measurements allows physicians to better predict an atrial fibrillation patient's risk of stroke or death. The tools also help determine ...

A recent British study published in European Heart Journal has reignited discussions on the role of sex as a determinant in prescribing anticoagulants, particularly for patients under the age of 65.

Biomarkers improve CHA2DS2-VASc model fit and predictive ability, with NTproBNP and GDF-15 yielding the best fit. (HealthDay News) — Biomarkers of ischemic stroke risk are positively associated with ...

DEAR DR. ROACH: I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I’ve been in normal sinus rhythm since having two catheter ablations in 2018. I take Eliquis ...

TCT 1049: Escalating Mortality from Pulmonary Embolism in U.S Women of Reproductive Age: A Retrospective Analysis (1999–2020) with Projections to 2030 Receive the the latest news, research, and ...

TCT 109: Analysis of Early Usage and Operator Attitudes Towards AI-assisted Analysis of IVUS Imaging on the AVVIGO+ System – a Single-centre Experience Receive the the latest news, research, and ...